Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWebb, L-
dc.contributor.authorShi, X-
dc.contributor.authorGoodair, C-
dc.contributor.authorCheeta, S-
dc.identifier.citationWebb, L., Shi, X., Goodair, C. and Cheeta, S. (2022) 'Trends in Mortality From Novel Psychoactive Substances as “Legal Highs”: Gender Differences in Manner of Death and Implications for Risk Differences for Women', Frontiers in Psychiatry, 13, 890840, pp. 1 - 9. doi: 10.3389/fpsyt.2022.890840.en_US
dc.descriptionData availability statement: The data analyzed in this study is subject to the following licenses/restrictions: Privately owned data. Requests to access these datasets should be directed to
dc.description.abstractCopyright © 2022 Webb, Shi, Goodair and Cheeta. Introduction: This study aimed to examine drug-related deaths in the UK in which novel psychoactive substances (NPS) are an implicated substance, and to focus on female deaths in comparison with male deaths. While male overdoses dominate epidemiological statistics, there is an increase in female drug-related deaths and a narrowing of the gap between gender mortality rates which is to date unexplained. Method: This study analyzed data from the National Programme for Substance Abuse Deaths (NPSAD) database that records drug-related deaths in the UK from coronial records. A dataset was constructed using parameters to capture all drug-related cases during the period 2007–2017 when NPS were legal and highly available in the UK, in order to capture deaths recorded among both regular and occasional drug users, and to include all cases recorded during that period regardless of NPS status in order to make comparisons. The final dataset comprised 10,159 cases, with 456 NPS-related deaths. Data for NPS and non-NPS were compared, and comparisons were made between cohorts by gender. The dataset also includes coronial narrative notes which allowed a qualitative analysis of NPS female deaths to add contextual explanation. Results: The proportion of male NPS deaths is significantly higher than that for female NPS deaths but does not reflect the generalized difference between male and female drug-related mortality of this period studied. Demographic and outcome data by gender difference were significant for all drug-related deaths, but not for NPS-only deaths, indicating a greater homogeneity among NPS deaths by gender. Older women using NPS were more likely to have methadone or diazepam as another drug implicated and have established histories of drug misuse. Conclusion: Where NPS have been used, differences in drug death profiles are less likely to be accounted for by gender than other demographic or behavioral differences more typically found in opiate deaths. The social and health problems of older women may be key characteristics that differentiate female deaths from male deaths. These findings also support evidence of increasing uptake of NPS among older established drug users that adds further risk to polydrug use.en_US
dc.format.extent1 - 9-
dc.publisherFrontiers Media SAen_US
dc.subjectnovel psychiatric substancesen_US
dc.subjectdrug mortalityen_US
dc.subjectdrug-related deathen_US
dc.subjectfemale mortalityen_US
dc.titleTrends in Mortality From Novel Psychoactive Substances as “Legal Highs”: Gender Differences in Manner of Death and Implications for Risk Differences for Womenen_US
dc.relation.isPartOfFrontiers in Psychiatry-
pubs.publication-statusPublished online-
Appears in Collections:Dept of Mathematics Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf210.39 kBAdobe PDFView/Open

Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.